A Phase 3 Clinical Study of
BMS-986489 Agent as
Investigational Treatment for
Extensive-stage SCLC
BMS-986489 Agent as
Investigational Treatment for
Extensive-stage SCLC
The TIGOS clinical study is currently open for enrollment
Check Your Eligibility